TITLE

Poster Presentations: 5. Cancer Genetics

PUB. DATE
September 2008
SOURCE
Journal of Medical Genetics;Sep2008 Supplement, Vol. 45 Issue 1, pS112
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents abstracts on cancer genetics which include the molecular testing for isolated phaeochromocytoma in the Oxford Molecular Genetics Laboratory, breast cancer subtypes and Manchester score, and biological ageing effect of radiotherapy in breast cancer.
ACCESSION #
34501992

 

Related Articles

  • Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype. Lazzeroni, M; Guerrieri-Gonzaga, A; Botteri, E; Leonardi, M C; Rotmensz, N; Serrano, D; Varricchio, C; Disalvatore, D; Castillo, A Del; Bassi, F; Pagani, G; DeCensi, A; Viale, G; Bonanni, B; Pruneri, G // British Journal of Cancer;4/30/2013, Vol. 108 Issue 8, p1593 

    Background:The post-surgical management of ductal intraepithelial neoplasia (DIN) of the breast is still a dilemma. Ki-67 labelling index (LI) has been proposed as an independent predictive and prognostic factor in early breast cancer.Methods:The prognostic and predictive roles of Ki-67 LI were...

  • Molecular and Functional Analysis of the SLIT2 Candidate Tumour Suppressor Gene in Breast Cancer.  // Journal of Medical Genetics;Sep2004 Supplement, Vol. 41, pS78 

    Presents an abstract of the study entitled "Molecular and Functional Analysis of the SLIT2 Candidate Tumour Suppressor Gene in Breast Cancer," by Rachel Dickinson, A. Dallol and F. Latif, presented during the British Human Genetics Conference held at the University of York in England from...

  • The molecular genetics of cancer: down the rabbit hole. Gunter, Chris // Human Molecular Genetics;Apr2001, Vol. 10 Issue 7, p655 

    Presents an overview of research developments in the molecular genetics of cancer. Varied effects of mutations in the same gee; Potential reversibility of epigenetic phenomena; Focus on breast cancer and colon cancer.

  • miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer. Crippa, Elisabetta; Lusa, Lara; De Cecco, Loris; Marchesi, Edoardo; Calin, George Adrian; Radice, Paolo; Manoukian, Siranoush; Peissel, Bernard; Daidone, Maria Grazia; Gariboldi, Manuela; Pierotti, Marco Alessandro // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    A miRNAs profiling on a group of familial and sporadic breast cancers showed that miRNA-342 was significantly associated with estrogen receptor (ER) levels. To investigate at functional level the role of miR-342 in the pathogenesis of breast cancer, we focused our attention on its “in...

  • Radiation Exposure, the ATM Gene, and Contralateral Breast Cancer in the Women's Environmental Cancer and Radiation Epidemiology Study. Bernstein, Jonine L.; Haile, Robert W.; Stovall, Marilyn; Boice Jr., John D.; Shore, Roy E.; Langholz, Bryan; Thomas, Duncan C.; Bernstein, Leslie; Lynch, Charles F.; Olsen, Jorgen H.; Malone, Kathleen E.; Mellemkjaer, Lene; Borresen-Dale, Anne-Lise; Rosenstein, Barry S.; Teraoka, Sharon N.; Diep, Anh T.; Smith, Susan A.; Capanu, Marinela; Reiner, Anne S.; Xiaolin Liang // JNCI: Journal of the National Cancer Institute;4/7/2010, Vol. 102 Issue 7, p475 

    Background: Ionizing radiation is a known mutagen and an established breast carcinogen. The ATM gene is a key regulator of cellular responses to the DNA damage induced by ionizing radiation. We investigated whether genetic variants in ATM play a clinically significant role in radiation-induced...

  • Genetic Features of Metachronous Esophageal Cancer Developed in Hodgkin’s Lymphoma or Breast Cancer Long-Term Survivors: An Exploratory Study. Boldrin, Elisa; Rumiato, Enrica; Fassan, Matteo; Cappellesso, Rocco; Rugge, Massimo; Chiarion-Sileni, Vanna; Ruol, Alberto; Alfieri, Rita; Cagol, Matteo; Castoro, Carlo; Amadori, Alberto; Saggioro, Daniela // PLoS ONE;Jan2015, Vol. 10 Issue 1, p1 

    Background: Development of novel therapeutic drugs and regimens for cancer treatment has led to improvements in patient long-term survival. This success has, however, been accompanied by the increased occurrence of second primary cancers. Indeed, patients who received regional radiotherapy for...

  • MEME KANSERÄ°NDE YEREL KONTROLE ETKÄ° EDEN PREDÄ°KTÄ°F MOLEKÃœLER VE GENETÄ°K FAKTÖRLER. Haydaroğlu, Ayfer // Meme Sagligi Dergisi / Journal of Breast Health;2012, Vol. 8 Issue 4, p169 

    Breast cancer is a heterogeneous group of different histological subtypes, which are based on various molecular and genetic factors. All patients are given radiotherapy after breast-conserving surgery, which is actually considered unnecessary in two-thirds of these patients. Therefore, the fact...

  • New Breast Cancer Treatment.  // Medical Update;Jul2002, Vol. 28 Issue 1, p7 

    Provides information on the MammoSite Radiation Therapy System for breast cancer.

  • CÂNCER DE MAMA: DE PERFIS MOLECULARES A CÉLULAS TRONCO. Zanetti, Juliana Silva; Oliveira, Lucinei Roberto; Ribeiro-Silva, Alfredo // Revista da Universidade Vale do Rio Verde;2011, Vol. 9 Issue 1, p277 

    Breast cancer is the most common malignant disease among women. Most breast cancers are resulted from genetic and epigenetic alterations that may change cellular morphology and functions. Breast cancer tumorigenesis and its progression are caused by the accumulation of these genetic alterations...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics